These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 10426383

  • 1. Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients.
    Riemens SC, van Tol A, Sluiter WJ, Dullaart RP.
    Diabetes; 1999 Aug; 48(8):1631-7. PubMed ID: 10426383
    [Abstract] [Full Text] [Related]

  • 2. Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport.
    Dullaart RP, van Tol A.
    Diabet Med; 2001 Jun; 18(6):509-13. PubMed ID: 11472472
    [Abstract] [Full Text] [Related]

  • 3. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
    Riemens SC, van Tol A, Sluiter WJ, Dullaart RP.
    Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
    [Abstract] [Full Text] [Related]

  • 4. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men.
    Riemens SC, Van Tol A, Stulp BK, Dullaart RP.
    J Lipid Res; 1999 Aug; 40(8):1467-74. PubMed ID: 10428983
    [Abstract] [Full Text] [Related]

  • 5. Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities.
    Riemens SC, Van Tol A, Sluiter WJ, Dullaart RP.
    J Lipid Res; 1999 Aug; 40(8):1459-66. PubMed ID: 10428982
    [Abstract] [Full Text] [Related]

  • 6. Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations.
    Dullaart RP, De Vries R, Scheek L, Borggreve SE, Van Gent T, Dallinga-Thie GM, Ito M, Nagano M, Sluiter WJ, Hattori H, Van Tol A.
    Scand J Clin Lab Invest; 2004 Aug; 64(3):205-15. PubMed ID: 15222630
    [Abstract] [Full Text] [Related]

  • 7. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S, van Tol A, Sluiter W, Dullaart R.
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients.
    Lagrost L, Athias A, Herbeth B, Guyard-Dangremont V, Artur Y, Paille F, Gambert P, Lallemant C.
    J Biol Chem; 1996 Aug 09; 271(32):19058-65. PubMed ID: 8702577
    [Abstract] [Full Text] [Related]

  • 10. Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification.
    Colhoun HM, Scheek LM, Rubens MB, Van Gent T, Underwood SR, Fuller JH, Van Tol A.
    Diabetes; 2001 Mar 09; 50(3):652-9. PubMed ID: 11246887
    [Abstract] [Full Text] [Related]

  • 11. Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids.
    Lagrost L, Mensink RP, Guyard-Dangremont V, Temme EH, Desrumaux C, Athias A, Hornstra G, Gambert P.
    Atherosclerosis; 1999 Feb 09; 142(2):395-402. PubMed ID: 10030391
    [Abstract] [Full Text] [Related]

  • 12. Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus.
    Tan KC, Shiu SW, Wong Y.
    Eur J Clin Invest; 2003 Apr 09; 33(4):301-6. PubMed ID: 12662160
    [Abstract] [Full Text] [Related]

  • 13. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism.
    Dullaart RP, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A.
    Eur J Clin Invest; 1994 Mar 09; 24(3):188-94. PubMed ID: 8033953
    [Abstract] [Full Text] [Related]

  • 14. Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin.
    Lagrost L, Athias A, Lemort N, Richard JL, Desrumaux C, Châtenet-Duchêne L, Courtois M, Farnier M, Jacotot B, Braschi S, Gambert P.
    Atherosclerosis; 1999 Apr 09; 143(2):415-25. PubMed ID: 10217372
    [Abstract] [Full Text] [Related]

  • 15. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA.
    Desrumaux C, Athias A, Bessède G, Vergès B, Farnier M, Perségol L, Gambert P, Lagrost L.
    Arterioscler Thromb Vasc Biol; 1999 Feb 09; 19(2):266-75. PubMed ID: 9974406
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy.
    Beentjes JA, van Tol A, Sluiter WJ, Dullaart RP.
    Scand J Clin Lab Invest; 2000 May 09; 60(3):189-98. PubMed ID: 10885490
    [Abstract] [Full Text] [Related]

  • 18. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans.
    Kujiraoka T, Nanjee MN, Oka T, Ito M, Nagano M, Cooke CJ, Takahashi S, Olszewski WL, Wong JS, Stepanova IP, Hamilton RL, Egashira T, Hattori H, Miller NE.
    Arterioscler Thromb Vasc Biol; 2003 Sep 01; 23(9):1653-9. PubMed ID: 12893687
    [Abstract] [Full Text] [Related]

  • 19. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men.
    Dullaart RP, Hoogenberg K, Dikkeschei BD, van Tol A.
    Arterioscler Thromb; 1994 Oct 01; 14(10):1581-5. PubMed ID: 7918308
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins.
    Lie J, de Crom R, Jauhiainen M, van Gent T, van Haperen R, Scheek L, Jansen H, Ehnholm C, van Tol A.
    Biochem J; 2001 Dec 01; 360(Pt 2):379-85. PubMed ID: 11716766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.